CN Stock MarketDetailed Quotes

Suzhou Fushilai Pharmaceutical (301258)

Watchlist
  • 35.03
  • +0.85+2.49%
Market Closed Jan 15 15:00 CST
3.21BMarket Cap42.26P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Suzhou Fushilai Pharmaceutical (301258) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Lipoic acid series147.83M66.02%
Carnosine series33.27M14.86%
艾瑞昔布26.59M11.88%
Phosphatidylcholine series13.32M5.95%
Other business2.9M1.29%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical main business426.01M99.19%
Other business3.46M0.81%

By Country/Region

Currency:CNY
2024/FY
Stock NameRevenueRatio
Domestic218.24M50.82%
Abroad211.23M49.18%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +30.13%
Sample Name
Sample Code
 +17.91%
Sample Name
Sample Code
 +15.43%
4
KUAISHOU-W
01024
+10.64%
5
JD HEALTH
06618
+9.43%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -